88
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Visual function correlates with foveal slope, retinal and choroidal thickness on optical coherence tomography in type 2 Macular Telangiectasia

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 524-530 | Received 18 Nov 2021, Accepted 09 Dec 2021, Published online: 29 Dec 2021

References

  • Charbel Issa P, Gillies MC, Chew EY, et al. Macular telangiectasia type 2. Prog Retin Eye Res. 2013;34:49–77. doi:10.1016/j.preteyeres.2012.11.002.
  • Gass JD, Blodi BA. Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study. Ophthalmology. 1993;100(10):1536–1546. doi:10.1016/S0161-6420(93)31447-8.
  • Yannuzzi LA, Bardal AMC, Freund KB, Chen K-J, Eandi CM, Blodi B. Idiopathic macular telangiectasia. Arch Ophthalmol. 2006;124(4):450–460. doi:10.1001/archopht.124.4.450.
  • Lamoureux EL, Maxwell RM, Marella M, Dirani M, Fenwick E, Guymer RH. The longitudinal impact of macular telangiectasia (MacTel) type 2 on vision-related quality of life. Invest Ophthalmol Vis Sci. 2011;52(5):2520–2524. doi:10.1167/iovs.10-6568.
  • Heeren TFC, Chew EY, Clemons T, et al., MacTel Study Group. Macular telangiectasia type 2: visual acuity, disease end stage, and the MacTel area. Ophthalmology. 2020;127(11):1539–1548. doi:10.1016/j.ophtha.2020.03.040.
  • Heeren TFC, Clemons T, Scholl HPN, Bird AC, Holz FG, Charbel Issa P. Progression of vision loss in macular telangiectasia type 2. Invest Ophthalmol Vis Sci. 2015;56(6):3905–3912. doi:10.1167/iovs.15-16915.
  • Venkatesh R, Pereira A, Bavaharan B, et al. Relevance of multicolor imaging in type 2 macular telangiectasia. J Curr Ophthalmol. 2020;32(4):375–380. doi:10.4103/JOCO.JOCO_96_20.
  • Park YG, Park Y-H. Quantitative analysis of retinal microvascular changes in macular telangiectasia type 2 using optical coherence tomography angiography. PLoS One. 2020;15(4):e0232255. doi:10.1371/journal.pone.0232255.
  • Govindahari V, Fraser-Bell S, Ayachit AG, et al. Multicolor imaging in macular telangiectasia—a comparison with fundus autofluorescence. Graefes Arch Clin Exp Ophthalmol. 2020;258(11):2379–2387. doi:10.1007/s00417-020-04878-3.
  • Vujosevic S, Heeren TFC, Florea D, et al. SCOTOMA CHARACTERISTICS IN MACULAR TELANGIECTASIA TYPE 2: mactel project report no. 7-the MacTel research group. Retina. 2018;38(Suppl 1):S14–9. doi:10.1097/IAE.0000000000001693.
  • Goel N, Kumari A, Kumar S, Mehta A. Multifocal electroretinography in patients with macular telangiectasia type 2. Doc Ophthalmol. 2020;141(1):15–21. doi:10.1007/s10633-019-09746-y.
  • Okada M, Robson AG, Egan CA, et al. Electrophysiological characterization of macular telangiectasia type 2 and structure-function correlation. Retina. 2018;38(Suppl 1):S33–42. doi:10.1097/IAE.0000000000001746.
  • Narayanan R, Dave V, Rani PK, et al. Multifocal electroretinography in type 2 idiopathic macular telangiectasia. Graefes Arch Clin Exp Ophthalmol. 2013;251(5):1311–1318. doi:10.1007/s00417-012-2191-5.
  • Kim YH, Chung YR, Oh J, et al. Demographic and multimodal imaging features of macular telangiectasia type 2: korean macular telangiectasia type 2 study - report no. 2. Ophthalmic Epidemiol. 2021;17:1–8.
  • Venkatesh R, Sinha S, Gangadharaiah D, et al. Retinal structural-vascular-functional relationship using optical coherence tomography and optical coherence tomography - angiography in myopia. Eye Vis (Lond). 2019;6:8. doi:10.1186/s40662-019-0133-6.
  • Tomiyasu T, Hirano Y, Suzuki N, et al. Structural and functional analyses of retinal ischemia in eyes with retinal vein occlusion: relationship with macular edema or microaneurysm formation. Ophthalmic Res. 2019;61(4):218–225. doi:10.1159/000493489.
  • Murakami T, Yoshimura N. Structural changes in individual retinal layers in diabetic macular edema. J Diabetes Res. 2013;2013:1–11. doi:10.1155/2013/920713.
  • Jaisankar D, Raman R, Gondhale H, Chhablani J, Agarwal M. visual function correlates of foveal slope changes on optical coherence tomography in macular telangiectasia type 2. Retina. 2017;37(12):2248–2253. doi:10.1097/IAE.0000000000001416.
  • Chhablani J, Kozak I, Jonnadula GB, et al. Choroidal thickness in macular telangiectasia type 2. Retina. 2014;34(9):1819–1823. doi:10.1097/IAE.0000000000000180.
  • Charbel Issa P, Helb H-M, Holz FG, Scholl HPN, MacTel Study Group. Correlation of macular function with retinal thickness in nonproliferative type 2 idiopathic macular telangiectasia. Am J Ophthalmol. 2008;145(1):169–175. doi:10.1016/j.ajo.2007.08.028.
  • Regatieri CV, Branchini L, Fujimoto JG, Duker JS. Choroidal imaging using spectral-domain optical coherence tomography. Retina. 2012;32(5):865–876. doi:10.1097/IAE.0b013e318251a3a8.
  • MacTel Study Group, Pauleikhoff D, Bonelli R, Dubis AM, et al. Progression characteristics of ellipsoid zone loss in macular telangiectasia type 2. Acta Ophthalmol. 2019;97(7):e998–1005. doi:10.1111/aos.14110.
  • Heeren TFC, Kitka D, Florea D, et al. Longitudinal correlation of ellipsoid zone loss and functional loss in macular telangiectasia type 2. Retina. 2018;38(Suppl 1):S20–6. doi:10.1097/IAE.0000000000001715.
  • Gillies MC, Zhu M, Chew E, et al. Familial asymptomatic macular telangiectasia type 2. Ophthalmology. 2009;116(12):2422–2429. doi:10.1016/j.ophtha.2009.05.010.
  • Koizumi H, Iida T, Maruko I. Morphologic features of group 2A idiopathic juxtafoveolar retinal telangiectasis in three-dimensional optical coherence tomography. Am J Ophthalmol. 2006;142(2):340–343. doi:10.1016/j.ajo.2006.03.021.
  • Kim YH, Chung YR, Oh J, et al. Optical coherence tomographic features of macular telangiectasia type 2: Korean macular telangiectasia type 2 study—report no. 1. Sci Rep. 2020;10(1):16594. doi:10.1038/s41598-020-73803-9.
  • Demir G, Cakir I, Alkin Z, Demircan A, Tulu B, Fazıl K. Evaluation of choroidal thickness in patients with proliferative and non-proliferative macular telangiectasia using enhanced depth imaging optical coherence tomography. Curr Eye Res. 2020;45(4):504–508. doi:10.1080/02713683.2019.1673437.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.